The number of known HTLVs has doubled with the identification of HTLV-3 and HTLV-4 in recent years. HTLVs are d-retroviruses that arose from simian retroviruses (STLV). The entire group of viruses, both human and simian, are now termed primate T-lymphotropic viruses (PTLV). PTLVs are numbered 1-4 and each is comprised of the corresponding HTLV and STLV-thus, PTLV-2 is made up of HTLV-2 and its ancestor, STLV-2 (the simian counterpart of HTLV-4 has not yet been identified).
HTLV-1 and HTLV-2 are widespread in the human population. HTLV-1 infection is associated with human disease in !5% of those infected, with the most frequent manifestations being human T-cell leukemia/lymphoma, myelopathy, and various inflammatory disorders. HTLV-2 may be associated with a myelopathic disorder. The distribution and potential disease associations of HTLV-3 and HTLV-4 are as yet unknown. The progenitor of HTLV-3, STLV-3, is broadly distributed in Africa, but only 3 strains of HTLV-3 have been identified to date-all in Cameroon. The only isolation of HTLV-4 so far has been from a primate hunter in the Cameroonian forest but, in contrast to the other HTLVs, the simian counterpart has not yet been identified.
Phylogenetic analysis of the HTLV-4 genome sequence demonstrated it to be distinct and equidistant from the other HTLVs, with only 62%-71% identity at the nucleotide level. The genome contains important sequences necessary for viral expression, including potential oncogenesis. Molecular dating indicates that the HTLV-4 lineage split off from a progenitor of PLTV-2 approximately 200,000 years ago, a time that more or less corresponds to the appearance of Homo sapiens 200,000-400,000 years ago.
The continued detection of previously unknown human viruses and retroviruses is opening a new chapter in our understanding of human health and disease. Whether HTLV-4 and/or HTLV-3 play an important role remains to be seen. Of the cryptococcal species considered pathogenic for humans, C. gattii is reported to account for only ∼1% of infections globally, although an accurate figure is not available due to the lack of routine speciation in many clinical laboratories. C. gatti has been reported to differ in a number of ecological and phenotypic factors from Cryptococcus neoformans [1] , and it has been suggested that it is more closely associated with infection of apparently immunocompetent hosts [2] . Because the geographic distribution of C. gattii has been associated with tropical and subtropical areas, its appearance on Vancouver Island, in the North American Pacific Northwest, indicating an apparent acquisition of new traits allowing colonization of a new biological and climatic niche, was surprising. The annual incidence of C. gattii infection on Vancouver Island, which is associated with a singly virulent strain (VGIIa), from 2002 to 2005 was 36 cases per million population, a rate ∼38-fold higher than in endemic regions of Australia. There is also recent evidence of spread of this organism to the nearby states of Washington and Oregon and to the Canadian mainland [1, 3] .
Cryptococcus gattii, Vancouver Island, and Mitochondrial Fusion
Ma and colleagues examined C. gattii isolates from the Vancouver Island outbreak in an attempt to identify characteristics accounting for its putative enhanced virulence. They were unable to identify any consistent difference in known accepted virulence traits by high-thoughput analysis of isolates both from Vancouver Island and from other regions of the world. Isolates from the Vancouver Island outbreak, however, demonstrated a markedly higher rate of proliferation within cultured macrophages and there was a strong correlation between this capacity and strain virulence in a murine model of infection. Transcriptional profiling identified a large number of upregulated genes in virulent strains, many of which are associated with mitochondria. Microscopic examination found that, instead of the usual diffuse or globular morphology, mitochondria from Vancouver Island isolates had a tubular morphology, a finding believed to be the result of mitochondrial fusion. Such fusion appears to protect cells from adverse mtDNA mutations and from apoptosis. The investigators propose that the Vancouver strains, upon being ingested by macrophages, are able to promote mitochondrial fusion, allowing more efficient repair of alterations to mtDNA that result from the adverse conditions within the phagosome, including hypoxia and reactive oxidative species.
These data strongly suggest that genetic changes in C. gattii, possibly the result of recombination events, led to an enhanced ability to not only survive within macrophages, but to actively replicate in that environment. The investigators also further hypothesize that this may be a more general phenomenon which may occur in other eukaryotic intracellular pathogens. Although these findings provide a potential explanation for the apparent enhanced virulence of the Vancouver Island outbreak strain of C. gattii, they do not ex-plain why this denizen of tropical and subtropical areas has acquired a new home in the Pacific Northwest. One possibility, of course, is the selection of adaptive mutations in this pathogen. An alternative, which is not mutually exclusive, is climate change. The bacterial mutator phenotype, characterized by hypermutability, usually as a consequence of defects in the DNA mismatch repair system, may play an important role in the emergence of antibacterial resistance in a variety of bacteria, including Streptococcus pneumoniae [1] . Bacterial resistance may also be horizontally ac-quired by acquisition of exogenous genetic material, a mechanism that occurs frequently among many streptococci as the result of their competence for genetic transformation, by which the acquisition of foreign DNA from the environment is facilitated. The uptake of DNA is followed by recombination events by which the DNA is inserted into the recipient's genome. Hanage and colleagues now provide evidence that some pneumococcal strains exhibit a hyper-recombination phenotype and that this phenotype is associated with greater antibiotic resistance.
Acquisition of Antibiotic Resistance in the Pneumococcus
The investigators applied multilocus sequence typing of 6 housekeeping genes to 1930 pneumococcal genotypes as well as to 94 genotypes from related species. They identified mosaic genotypes which were the result of admixture between populations indicating past recombination events. Furthermore, these events occurred not only within the pneumococcal species but also with related species and were both legitimate (requiring homology between donor and recipient DNA) and illegitimate (sitespecific, nonhomologous). This general tolerance to foreign DNA is suggested by the investigators to represent a hyper-recombinant state which allows for ready transfer of, among other things, antibiotic resistance determinants.
S. pneumoniae, along with 11 other species which are respiratory commensals, is a member of the mitis group of streptococci, a group in which homologous re-combination occurs frequently [2] . Some members, such as Streptococcus oralis and Streptococcus mitis, are so closely genetically related to S. pneumoniae as to raise questions about their designation as separate species and the clinical microbiology laboratory may, at times, have difficulty distinguishing between S. mitis and S. pneumoniae. Previous work had demonstrated the acquisition by S. pneumoniae of antibiotic resistance from S. mitis, and in addition, pneumococcal virulence gene homologs have been detected in other members of the mitis group [5]. Thus, one consequence of the genetic relatedness of these organisms is the ready transfer of DNA, including genes encoding antibiotic resistance. The ability of S. pneumoniae and related streptococci to accept nonhomologous DNA, an indicator of a hyper-recombinant state, facilitates the spread of various characteristics, including antibiotic resistance, in these organisms and, most importantly, in the virulent human pathogen, S. pneumoniae.
